GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 101 filers reported holding GENOMIC HEALTH INC in Q1 2014. The put-call ratio across all filers is 4.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,206,000 | +156.9% | 474,874 | +120.3% | 0.03% | +25.9% |
| Q2 2019 | $12,538,000 | +9.5% | 215,537 | +31.8% | 0.03% | +8.0% |
| Q1 2019 | $11,453,000 | +60.5% | 163,500 | +47.6% | 0.02% | +38.9% |
| Q4 2018 | $7,137,000 | +32.0% | 110,800 | +43.9% | 0.02% | +63.6% |
| Q3 2018 | $5,407,000 | +23.9% | 77,000 | -11.1% | 0.01% | +10.0% |
| Q2 2018 | $4,365,000 | +34.9% | 86,600 | -16.2% | 0.01% | +25.0% |
| Q1 2018 | $3,235,000 | +5.6% | 103,400 | +15.4% | 0.01% | 0.0% |
| Q4 2017 | $3,064,000 | +20.3% | 89,600 | +12.4% | 0.01% | -27.3% |
| Q4 2014 | $2,548,000 | +9.0% | 79,700 | -3.5% | 0.01% | 0.0% |
| Q3 2014 | $2,338,000 | -34.4% | 82,600 | -36.5% | 0.01% | -35.3% |
| Q2 2014 | $3,562,000 | +42.8% | 130,000 | +37.3% | 0.02% | +41.7% |
| Q1 2014 | $2,494,000 | -6.7% | 94,700 | +3.7% | 0.01% | -14.3% |
| Q4 2013 | $2,672,000 | -33.4% | 91,300 | -30.5% | 0.01% | -36.4% |
| Q3 2013 | $4,015,000 | -32.9% | 131,300 | -30.4% | 0.02% | -35.3% |
| Q2 2013 | $5,981,000 | – | 188,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,458,100 | $76,914,000 | 3.78% |
| Baker Brothers Advisors | 13,789,936 | $431,487,000 | 3.66% |
| Millrace Asset Group, Inc. | 147,500 | $4,081,000 | 1.98% |
| EMORY UNIVERSITY | 79,591 | $2,490,000 | 1.78% |
| Aurora Investment Counsel | 56,055 | $1,754,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 80,903 | $2,531,000 | 0.47% |
| Spark Investment Management LLC | 101,400 | $3,172,000 | 0.20% |
| ALGERT GLOBAL LLC | 28,720 | $899,000 | 0.17% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 64,346 | $2,013,000 | 0.15% |
| Alambic Investment Management, L.P. | 21,600 | $676,000 | 0.09% |